Danish devices association urges authorities to deter reuse firm
This article was originally published in Clinica
Executive Summary
Denmark's state serum institute (SSI) has denied suggestions that it has in any way approved the practices of German medical devices reprocessing company Vanguard. This statement comes despite the publication of a report by SSI in which it claims that the resterilisation of single-use devices is defensible "in certain cases". In reply to a letter from Medicoidustrien, the medical devices industry association, SSI said that it did not even have the authority to approve such procedures.